PharmGen Science, Inc. (004720.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 91.22B |
| Enterprise Value | 75.34B |
| P/E Ratio | -0.49 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0.38 |
| Price/Book Ratio | 0.48 |
| Enterprise/Revenue | 0.27 |
| Enterprise/EBITDA | 5.53 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.77 |
| Operating Margin | 0.02 |
AD
Management Effectiveness
| Return On Assets | -0.73 |
| Return On Equity | -0.79 |
Income Statement
| Revenue | 173.07B |
| Revenue/Share | 7,926.99 |
| Gross Profit | 109.13B |
| EBITDA | 10.53B |
| Net Income | -116.64B |
| Diluted EPS | -5,312.85 |
Balance Sheet
| Total Cash | 20.05B |
| Total Cash/Share | 906.42 |
| Total Debt | 698.14M |
| Total Debt/Equity | 0 |
| Current Ratio | 3.33 |
| Book Value Per Share | 6,330.33 |
Price History
| 52-Week Change | -33.81 |
| 52-Week High | 4,600 |
| 52-Week Low | 2,590 |
| Moving Average 50 Days | 3,219.4 |
| Moving Average 200 Days | 3,683.2 |
Statistics
| Average Volume | 33,412 |
| Shares Outstanding | 21.91M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | December 09, 2014 |
AD
